Teizo Yoshimura

13PUBLICATIONS
18CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 12, 2026
Advances in Immune Checkpoint Inhibitors for Cancer Treatment.

|Apr 14, 2026
CXCR2-Dependent Infiltration of Tumor-Associated Neutrophils Is Linked to Enhanced CD8+ T Cell Effector Function and Reduced Lung Metastasis in 4T1 Breast Cancer.

Tiantian Li, Teizo Yoshimura, Miao Tian

|Oct 29, 2025
Neurofibromin Encoded by the Neurofibromatosis Type 1 (NF1) Gene Promotes the Membrane Translocation of SPRED2, Thereby Inhibiting the ERK Pathway in Breast Cancer Cells.

Nang Thee Su Pwint, Chunning Li, Tong Gao

|Jun 19, 2024
SPRED2 Is a Novel Regulator of Autophagy in Hepatocellular Carcinoma Cells and Normal Hepatocytes.

Tianyi Wang, Tong Gao, Masayoshi Fujisawa

|May 31, 2024
The specific shapes of capillaries are associated with worse prognosis in patients with invasive breast cancer.

Hnin-Wint-Wint Swe, Masayoshi Fujisawa, Toshiaki Ohara

|May 19, 2023
The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis.

Teizo Yoshimura, Chunning Li, Yuze Wang

Pageof 3

Frequent Collaborators

5 joint publications

Toshiaki Ohara

5 joint publications

Akihiro Matsukawa

3 joint publications

Masakiyo Sakaguchi

2 joint publications

Yuze Wang